BIOAF
BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc. (BIOAF)
$
00About BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc. (BIOAF)
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--